Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1007345

[Cl-].[Cl-].[Ru+2]=Cc1ccccc1.c1cn(C2CCCCC2)c(=P(C2CCCCC2)(C2CCCCC2)C2CCCCC2)n1C1CCCCC1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.31
KDM4E B2RXH2 1/20 0.30
IL4I1 Q96RQ9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17836900 0.79
Hydrochloric Acid SCHEMBL2223643 0.79 HPGD (0.32)
SCHEMBL7247588 0.79
Hydrochloric Acid SCHEMBL1007232 0.78 HSD11B1 (0.35) SLC18A3KDM4E
Hydrochloric Acid SCHEMBL1006744 0.75
Hydrochloric Acid SCHEMBL1004607 0.74
Hydrochloric Acid SCHEMBL4523224 0.74 KDM4E (0.31) KDM4E
Hydrochloric Acid SCHEMBL1006196 0.72 CYP2D6 (0.36)
Hydrochloric Acid SCHEMBL17836926 0.69 TSHR (0.38) SLC18A3
Hydrochloric Acid SCHEMBL17836910 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10358400-B2 Method for producing olefin containing chlorine and fluorine AGC Inc. (JP) 2019-07-23 US disclosed
EP-3266758-B1 PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND AGC INC (JP) 2019-06-19 EP disclosed
US-10252959-B2 Method for producing fluorine-containing olefin compound AGC Inc. (JP) 2019-04-09 US disclosed
EP-3266758-A1 PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND Asahi Glass Company, Limited (JP) 2018-01-10 EP disclosed
US-20170369402-A1 PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND ASAHI GLASS COMPANY, LIMITED (JP) 2017-12-28 US disclosed
EP-3257885-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER Asahi Glass Company, Limited (JP) 2017-12-20 EP disclosed
US-20170335051-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER ASAHI GLASS COMPANY, LIMITED (JP) 2017-11-23 US disclosed
EP-3239126-A1 METHOD FOR PRODUCING OLEFIN CONTAINING CHLORINE AND FLUORINE Asahi Glass Company, Limited (JP) 2017-11-01 EP disclosed
US-9796647-B2 Method for producing fluorine-containing olefin ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-24 US disclosed
US-20170291863-A1 METHOD FOR PRODUCING OLEFIN CONTAINING CHLORINE AND FLUORINE ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-12 US disclosed
US-20110177239-A1 METHODS FOR MANUFACTURING ORGANIC-INORGANIC COMPOSITE PARTICLES, OPTICAL MATERIAL, OPTICAL ELEMENT AND LENS, AND ORGANIC-INORGANIC COMPOSITE PARTICLES CANON KABUSHIKI KAISHA (JP) 2011-07-21 US disclosed
EP-1197509-B1 PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN ZEON CORP (JP) 2011-07-06 EP disclosed
EP-2270063-A2 Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization NIPPON ZEON CO., LTD. (JP) 2011-01-05 EP disclosed
EP-1275675-B1 COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE ZEON CORP (JP) 2005-12-07 EP disclosed
US-6908970-B2 Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization ZEON CORPORATION (JP) 2005-06-21 US disclosed
US-6815516-B2 HEAT RESISTANCE, SOLVENT SOLUBILITY ZEON CORPORATION (JP) 2004-11-09 US disclosed
US-20030050406-A1 Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization ZEON CORPORATION 2003-03-13 US disclosed
US-20030018138-A1 Copolymer formed by ring -opening polymerization, product of hydrogenation of copolymer formed by ring-opening polymerization, and process for producing these ZEON CORPORATION (JP) 2003-01-23 US disclosed
EP-1275675-A1 COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE Zeon Corporation (JP) 2003-01-15 EP disclosed
EP-1197509-A1 PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN Nippon Zeon Co., Ltd. (JP) 2002-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369402-A1 PRODUCTION METHOD FOR FLUORINE-CONTAINING OLEFIN COMPOUND FOS, FOSB, CYP4F11 SLC18A3 3246/4885KDM4E 4021/4885IL4I1 2362/4885
US-10252959-B2 Method for producing fluorine-containing olefin compound FOS, FOSB, CYP4F11 SLC18A3 3006/4885KDM4E 4038/4885IL4I1 3261/4885
US-10358400-B2 Method for producing olefin containing chlorine and fluorine CYP2F1, CYP4F11, CYP4F2 SLC18A3 3268/4885KDM4E 3866/4885IL4I1 859/4885
US-20170291863-A1 METHOD FOR PRODUCING OLEFIN CONTAINING CHLORINE AND FLUORINE CYP2F1, CYP4F11, CYP4F2 SLC18A3 3268/4885KDM4E 3866/4885IL4I1 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.